AI based Pharma Insights

are presented as online trackers or PowerPoint presentations by Pharma and

Market Research experts.

Mavis, understands the medical lexicon and is able to independently analyze, aggregate and present complex insights in a user-friendly way. The humans-in-the-loop, pharma and medical experts, train the engine, building the framework for analysis and interpret the insights. Indication and country specific insights are gathered by processing information from a vast array of sources including medical communities, research forums, patient-doctor discussion groups, conference and academic publications and other publicly available information on research and approval.

Graphene’s Pharma AI uses cutting edge

technology to provide an in-depth understanding of patients/caregivers and HCPs

for a specific indication in a country. By providing deep and actionable insight on

the challenges faced by Patients, Caregivers and HCPs we enable Pharma

companies with the information necessary to have a deep understanding of not

just the behaviors of patients and HCPs but also the reasons for the

behaviors. We model behavior and predict

how patients, caregivers and HCPs would respond to new and existing diagnosis

and treatment protocols. This

understanding helps Pharma majors address the gaps in access, care and support,

improving not just treatment but the quality-of-life as well. These deep insights cover the entire patient

journey from testing and treatment to beyond-the-pill patient support and

access programs.

The insight is provided at a regular

cadence and at less expense than traditional research methods and performed for

all indications, including rare and ultra-rare diseases and most geographies

including emerging markets.